García HJF, Villalobos VJ, Martínez JIE, Jara PA, Ochoa MA, Toledo A, Marie FAO

Language: Spanish
References: 19
Page: 17-22
PDF size: 207.51 Kb.

ABSTRACT

Epilepsy is a disorder with high prevalence worldwide, particularly in developing countries. It has been shown that epilepsy is associated with a local inflammatory reaction, with astrocyte and microglia activation and secretion of proinflammatory mediators. In addition there is evidence to suggest that central proinflammatory states increase the possibility of developing crisis; also it was shown that systemic inflammation lowers seizure threshold in several experimental models of peripheral inflammation.
Objective: To determine if a systemic “pro-inflammatory” state may contribute to the lack of control of seizures in patients with juvenile myoclonic epilepsy (JME).
Methods: 30 patients treated at INNN since 2005 were included. An ad-hoc questionnaire was applicated to assess 1) the frequency and intensity of pro-inflammatory factors in the two months period previous to the interview, and 2) seizure frequency in this period and their characteristics. Possible associations between these two parameters were evaluated.
Results: The statistical analysis did not found significant associations between the intensity of peripheral pro-inflammatory factors and uncontrolled epilepsy.
Conclusions: These results seem to show that systemic inflammatory status is not involved in the control of seizures in patients with JME. These results are preliminary and will be completed by the measurement of pro- and anti-inflammatory proteins in the sera of affected patients.

REFERENCES

1. Ngugi Anthony K, Bottomley C, Kleinschmidt I, Sander JW, Charles RN. Estimation of the Burden of Active and Lifetime Epilepsy: a meta-analytic Approach. Epilepsia 2010;51: 883–890.

2. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;55: 475-482.3. Vezzani A, French J, Bartfai T, Baram T. The role of inflammation in epilepsy. Nat Rev Neurol 2010;7: 31- 40.

3. Xu D, Miller S, Koh S. Immune mechanism in epileptogenesis. Front Cell Neurosci 2013;7: 11-19.

4. Bien CG, Urbach H, Schramm J, Soeder BM, Becker AJ, Voltz R, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 2007;69:1236–44.

5. Choi J, Sookyong K. Role of brain inflammation in epileptogenesis. Yonsei Medical Journal 2008;49:1–18.

6. Orrin D, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: Excitability and inflammation. Trends Neurosci 2013;36:174–84.

7. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000;12:2623–33.

8. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic over expression in Mice. Proc Natl Acad Sci U S A 2000;10:11534–9.

9. Vezzani A, Granata T. Brain inflammation in epilepsy: Experimental and clinical evidence. Epilepsia 2005;46:1724–43.

10. Falip M, Salas X, Cara C. Causes of CNS inflammation and potential targets for anticonvulsants. CNS drugs. 2013; 27: 611-23.

11. Xu D, Miller S, Koh S. Immune mechanism in epileptogenesis. Front Cell Neurosci 2013; 7: 11-9.

12. Kiarash R, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ. Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A 2008;105:17151–6.

13. León J, Mateos H, Martínez I. Anormalidades en RM, EEG y respuesta al tratamiento en epilepsia mioclónica juvenil. Arch Neurocien (Mex) 2010;15:12-6.

14. Crespel A, Gelisse P, Reed R. Management of juvenile myoclonic epilepsy. Epilepsy Behav 2013;28:81-6.

15. Koepp M, Thomas RH, Wandschneider B, Berkovic SF, Schmidt D. Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy. Expert Rev Neurother 2014;14:819-31.

16. Alfradique I, Vasconcelos M. Juvenile myoclonic epilepsy. Arq Neuro-Psiquiatr 2007; 65:1266–71.

17. Genton P, Thomas P, Dorothee GA, Trenité K., Medina M., Salas Puig J. Clinical aspects of juvenile myoclonic epilepsy. Epilepsy Behav 2013;28: S8–S14.

18. Höflera J, Unterbergerb I, Dobesbergera J, Kuchukhidzea G, Walserb G, Trinkaa E. Seizure outcome in 175 patients with juvenile myoclonic epilepsy - A long-term observational study. Epilepsy Res 2014;108:1817-24.

19. Luo J, Wang W, Xi Z, Dan C, Wang L, Xiao Z, et al. Concentration of soluble adhesion molecules in cerebrospinal fluid and serum of epilepsy patients. J Mol Neurosci. 2014;54:767-73.